Taylor Wessing advises Vivacta on £6 million Series B fundraising

05-Dec-2007  |  Corporate, Life Sciences & Healthcare

CLIENT

Vivacta Limited

VALUE

£6 million

TRANSACTION

Series B fundraising round

DESCRIPTION

Taylor Wessing in London has acted for Vivacta Limited on a £6 million Series B fundraising round.

European Venture Capital firms HBM BioVentures and AGF Private Equity led the £6 million investment in Vivacta Limited. Vivacta's existing investors, Spark Ventures and Viking Technologies, also invested alongside HMB and AGF.